First Choice Healthcare Solutions, Inc. earns about 35% on equity, but has diluted owners by 24% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below. Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2017 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | $3.89M1 | −$9.94M2 | −$8.17M3 | −$3.85M4 | −$6.96M4 |
| Operating cash flow | −$1.55M5 | −$3.38M6 | −$6.8M7 | −$1.71M8 | −$549,0198 |
| Capital expenditure | $330,4399 | $80,68010 | $82,91811 | — | — |
| Free cash flow (derived) | −$1.89M5,9 | −$3.46M6,10 | −$6.88M7,11 | — | — |
| Total debt | $2.69M12 | $1.11M13 | $2.91M14 | $3.08M14,15 | — |
| Cash & equivalents | $2.02M16 | $7,21917 | $12,60718 | $19,91519 | $5,89619 |
| Diluted shares | 26.7M | 33.0M | 33.0M | 33.0M | 33.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom). A derived or summed figure cites every filing line it was built from.
10 shares is a claim on −$11.99 of net worth that earned you −$2.11 last year.
It earned an average 35% on equity over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 24% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has risen 14% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
This page is free, and so is every other company on MeritValue.
Connect the MeritValue MCP server to Claude or another MCP client, ask about First Choice Healthcare Solutions, Inc., and get these exact figures with their filing receipts — not an improvised DCF.
Get a free key →Pull the companies with a published value under any model (up to 500 a request, filtered by data completeness) into your own sheet or agent. Screening is what Analyst adds, at $9/month.
See pricing →Follow FCHS and keep your own price beside the value. The same engine, with the same receipts.
MeritValue on the App Store →- 10-K/A filed 2018-04-03 · period ending 2017-12-31 · accession 0001575705-18-000046 (NetIncomeLoss)
- 10-K filed 2024-05-13 · period ending 2022-12-31 · accession 0001493152-24-018817 (NetIncomeLoss)
- 10-K filed 2025-04-15 · period ending 2023-12-31 · accession 0001641172-25-004752 (NetIncomeLoss)
- 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001493152-26-009679 (NetIncomeLoss)
- 10-K/A filed 2018-04-03 · period ending 2017-12-31 · accession 0001575705-18-000046 (NetCashProvidedByUsedInOperatingActivitiesContinuingOperations)
- 10-K filed 2024-05-13 · period ending 2022-12-31 · accession 0001493152-24-018817 (NetCashProvidedByUsedInOperatingActivities)
- 10-K filed 2025-04-15 · period ending 2023-12-31 · accession 0001641172-25-004752 (NetCashProvidedByUsedInOperatingActivities)
- 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001493152-26-009679 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A filed 2018-04-03 · period ending 2017-12-31 · accession 0001575705-18-000046 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K filed 2024-05-13 · period ending 2022-12-31 · accession 0001493152-24-018817 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K filed 2025-04-15 · period ending 2023-12-31 · accession 0001641172-25-004752 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K/A filed 2018-04-03 · period ending 2017-12-31 · accession 0001575705-18-000046 (LongTermDebtNoncurrent)
- 10-K filed 2024-05-13 · period ending 2022-12-31 · accession 0001493152-24-018817 (NotesPayable)
- 10-K filed 2025-04-15 · periods ending 2023-12-31, 2024-12-31 · accession 0001641172-25-004752 (NotesPayable)
- 10-K filed 2025-04-15 · period ending 2024-12-31 · accession 0001641172-25-004752 (LoansPayable)
- 10-K/A filed 2018-04-03 · period ending 2017-12-31 · accession 0001575705-18-000046 (CashAndCashEquivalentsAtCarryingValue)
- 10-K filed 2024-05-13 · period ending 2022-12-31 · accession 0001493152-24-018817 (CashAndCashEquivalentsAtCarryingValue)
- 10-K filed 2025-04-15 · period ending 2023-12-31 · accession 0001641172-25-004752 (CashAndCashEquivalentsAtCarryingValue)
- 10-K filed 2026-03-11 · periods ending 2024-12-31, 2025-12-31 · accession 0001493152-26-009679 (CashAndCashEquivalentsAtCarryingValue)